"
Treatment Initiation among Patients with Multidrug Resistant Tuberculosis in Bhopal District, India"
written by Hemant Deepak Shewade, Arun M. Kokane, Akash Ranjan Singh, Manoj Verma, Malik Parmar, Sanjay Singh Chahar, Manoj Tiwari, Sheeba Naz Khan, Mukesh Nagar, Sanjai Kumar Singh, Pradeep Kumar Mehra, Ajay M. V. Kumar,
published by
Journal of Tuberculosis Research,
Vol.5 No.4, 2017
has been cited by the following article(s):
[1]
|
OTOTOXICITY IN MDR-TB PATIENTS ON CATEGORY-4 REGIMEN: A CASE REPORT
|
|
ERA’S JOURNAL OF MEDICAL RESEARCH,
2020 |
|
|
[2]
|
Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors
|
|
2019 |
|
|
[3]
|
approved with reservations, 1 not approved
|
|
2018 |
|
|
[4]
|
Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India
|
|
Public Health Action,
2018 |
|
|
[5]
|
Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from …
|
|
PLOS ONE,
2018 |
|
|
[6]
|
Pre-diagnosis attrition in patients with presumptive MDR-TB in Bhopal, India, 2015: a follow-up study
|
|
2018 |
|
|
[7]
|
Pre-treatment loss to follow-up among patients with rifampicin-resistant tuberculosis in Baluchistan, Pakistan, 2012-17: a retrospective cohort study
|
|
2018 |
|
|
[8]
|
Pre-treatment loss to follow-up among patients with rifampicin-resistant tuberculosis in Baluchistan, Pakistan, 2012-17: a retrospective cohort study?[version 1; referees: awaiting peer review]
|
|
F1000Research,
2018 |
|
|
[1]
|
Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors
PLOS ONE,
2019
DOI:10.1371/journal.pone.0214943
|
|
|
[2]
|
Provider reported barriers and solutions to improve testing among tuberculosis patients ‘eligible for drug susceptibility test’: A qualitative study from programmatic setting in India
PLOS ONE,
2018
DOI:10.1371/journal.pone.0196162
|
|
|
[3]
|
Pre-treatment loss to follow-up among patients with rifampicin-resistant tuberculosis in Baluchistan, Pakistan, 2012-17: a retrospective cohort study
F1000Research,
2018
DOI:10.12688/f1000research.17057.1
|
|
|